PriceMDs.com Launches Regional Advertising Campaign

PriceMDs.com, the fast growing Healthcare Provider/Patient search engine, launched its first TV advertising campaign today on Bright House Networks. The 30-second TV spot is expected to reach an audience of well over one million viewers in the greater Tampa Bay area as the company is introducing its growing website to its first major market.

“We are very excited to have reached this very significant milestone!” said Marc Grossman MD, chief executive officer of PriceMDs.com. “Our commercials on Bright House Networks in Tampa Bay is just the beginning of what will become a full scale marketing campaign across the nation. With well-calculated and careful steps we move forward as we open new markets and introduce PriceMDs.com to the patients/consumers. We are focused on providing a positive new approach to healthcare for the patient while helping our healthcare providers grow their practices, improve their patient retention, and reduce advertising costs.” Dr Grossman concluded.

PriceMDs.com, whose target demographic group is consumers between the ages of 25 to 65, has developed a multi-patent pending search engine that connects patients with Health-Care Professionals. This product is the “Hotels.com” for Health-Care Professionals and those seeking Health-Care. It’s always free to the patient while the Health-Care Professional pays a small search fee, but only when a patient clicks to schedule and appointment. PriceMDs.com is the only truly “success-based” advertising platform that allows the patient to search by all-inclusive price, location, health-care professional, procedure, or service. The patient can view pictures of the Health-Care Professional, the office, the staff, read reviews, care philosophies, all from a desktop, lap-top, tablet, or smart phone by app or website.

Contact: 
Nick Tsolakakis
nick@PriceMDs.com
727-470-8343

New Online Clinical Trials Guide Showcases Benefits for Cancer Patients


Washington, DC – At a time when fewer than 5 percent of adults with cancer enroll in a clinical trial, an initiative called Project Innovation unveiled the Clinical Trials Resource Guide, a comprehensive web-based aide that explains why taking part in a clinical study is a way for patients to receive either the best treatment currently known for their cancer from the leading experts in the field, or to be treated with a promising, new therapy not available yet to all patients. Project Innovation is a campaign to elevate cancer innovation as a national priority.

Because lack of awareness is a pervasive barrier to more patients taking part in clinical trials, the online resource dispels some widespread misperceptions about these studies, including the myth that some individuals get a placebo instead of the best treatment or must travel long distances to take part in a study. As such, the guide relays the value of clinical trials from the patient perspective, answers the questions on patients’ minds, and provides a “one-stop” resource for patients to discuss the option of a clinical study with their oncologist and locate available trials. The online guide also provides links to patient stories so Americans can hear directly about the experiences of others. The Clinical Trials Resource Guide is available on the Project Innovation website at: http://bit.ly/1ee8YVb.

“Enrolling adequate numbers of eligible cancer patients in clinical trials is an ongoing problem for biomedical researchers and is largely due to a pervasive lack of understanding among Americans of what a clinical trial is, what it means to participate in one and how patients will benefit,” said Alan Balch, PhD, chief executive officer of the Patient Advocate Foundation, which manages Project Innovation.  “Our goal is to close this knowledge gap by providing user-friendly information on cancer clinical trials to guide patients and caregivers so they can make the decision that is best for them.”

Confronting the Perception Barriers on Cancer Clinical Trials
Although clinical trials are a treatment option for all types of cancer, research shows only 2-5 percent of the 14.5 million Americans with a history of cancer participate in these studies. While a number of factors are involved, misperceptions of what clinical trials entail, lack of awareness of clinical trial availability and concerns about practical issues, such as the costs to patients, remain some of the most challenging.

  • Because addressing these perception barriers is necessary to increase accrual rates, the new online resource guide confronts the myths about clinical trials head-on by relaying these important facts:
  • Cancer clinical trials take place in doctors’ offices, clinics, cancer centers and hospitals around the country – meaning enrolled patients can get expert medical care in their own communities
  • Clinical trials are offered for all stages of cancer, including for newly diagnosed patients
  • All patients who join a clinical trial are given the best cancer treatment options available or the chance to receive a new treatment being considered
  • Costs directly related to the study – the drugs used, tests, procedures, and doctor visits – are covered by the sponsor of the study.  In many cases, routine patient costs, such as extra doctor visits, are covered by the sponsor or by insurance including Medicare
  • At any time, a patient can leave a cancer clinical trial for any reason, without giving up access to other treatment

About Project Innovation and the Cancer Innovation Coalition
Project Innovation is a national movement designed to accelerate the pace of medical discovery in cancer, deliver safe and effective breakthrough therapies to patients quickly and save lives.   Through Project Innovation and its complimentary policy development initiative, the Cancer Innovation Coalition, stakeholders have joined forces to address the barriers slowing the pace of biomedical research, including factors that affect the clinical trials process in the U.S.

Launched in June 2014, Project Innovation followed the release of the National Patient Advocate Foundation’s report, Securing the Future of Innovation in Cancer Treatment, which identified institutional, regulatory and funding hurdles that are driving up the costs and delaying the development of new cancer therapies – factors that ultimately limit patient access to much needed treatment. To overcome these obstacles, the report provides a blueprint for action, suggesting policy solutions, research collaborations, data sharing concepts and funding options that can significantly advance innovation.  More information about Project Innovation is available at www.projectinnovation.org @projectinno on Twitter and https://facebook.com/ProjectInno on Facebook.

About Patient Advocate Foundation (PAF)
Established in 1996, Patient Advocate Foundation assists patients who have been diagnosed with serious illness overcome healthcare access barriers. PAF provides in-depth assistance through personalized case management, financial support, and connection to critical community resources.  PAF serves uninsured and insured patients all across the country at no charge to help overcome and resolve insurance-related and financial obstacles that impact care.   

Patient Advocate Foundation has numerous patient-focused programs that aid seriously ill patients during their medical journey, including free case management, co-payment assistance for medications and the option to apply for specific financial grants through the financial aid fund division.  In addition, PAF offers education and guidance to all consumers nationwide through its 30+ publications and expert materials.   For more information about Patient Advocate Foundation and their mission to improve health access to all patients, visit www.patientadvocate.org or call 1 (800) 532-5274.

Attorney William Miceli has Achieved the AV Preeminent® Rating – the Highest Possible Rating from Martindale-Hubbell®.

William Miceli, a lawyer based in Chicago, IL whose primary area of practice is Affordable Housing, has earned the AV Preeminent® rating from Martindale-Hubbell®

Chicago, IL (PR Newswire) July 27, 2015 – Martindale-Hubbell® has confirmed that attorney William Miceli still maintains the AV Preeminent Rating, Martindale-Hubbell’s highest possible rating for both ethical standards and legal ability, even after first achieving this rating in 2013.

For more than 130 years, lawyers have relied on the Martindale-Hubbell AV Preeminent® rating while searching for their own expert attorneys. Now anyone can make use of this trusted rating by looking up a lawyer’s rating on Lawyers.com or martindale.com. The Martindale-Hubbell® AV Preeminent® rating is the highest possible rating for an attorney for both ethical standards and legal ability. This rating represents the pinnacle of professional excellence. It is achieved only after an attorney has been reviewed and recommended by their peers – members of the bar and the judiciary. Congratulations go to William Miceli who has achieved the AV Preeminent® Rating from Martindale-Hubbell®.

William Miceli commented on the recognition: “The Martindale-Hubbell AV Preeminent Rating is a credential highly valued and sought after in the legal world. It used to be a sort of secret among attorneys who used the rating as a first screen when they needed to hire a lawyer they did not personally know. Now, thanks to the Internet, the Rating is a great way for anyone ñ lawyers or lay people – to use to screen lawyers. I am thankful to my peers who nominated me for this distinction, and proud to have earned this, the highest possible Martindale-Hubbell rating.”

About William Miceli: a short profile by and about the honoree:

William Miceli concentrates his practice in the areas of not for profit law, including affordable housing and economic development transactions, Federally Qualified Health Centers, and social services.

The plaque shown here commemorates William Miceli’s recognition.

To find out more or to contact William Miceli of Chicago, IL, call 312-751-1170, or visit http://www.lawmbg.com.

As a result of this honor, American Registry LLC, has added William Miceli to The Registry™ of Business and Professional Excellence. For more information, search The Registry™ at http://www.americanregistry.com.

This press release was written by American Registry, LLC, with approval by Martindale-Hubbell as well as approval and/or contributions from William Miceli; it was distributed by PR Newswire, a subsidiary of UBM plc.

Contact Information:
William Miceli

Phone: 312-751-1170

Email Address: wmiceli@lawmbg.com

Website: http://www.lawmbg.com

Attorney William Miceli has Achieved the AV Preeminent® Rating – the Highest Possible Rating from Martindale-Hubbell®.

Dr. Carlos Ayala Wins Prestigious Vitals Patients’ Choice Award

Seventh Annual Vitals Patients. Choice Award Recognizes Dr. Carlos Ayala for Outstanding Care Based on Patient Feedback

Mcallen, TX — July 24, 2015 — Vitals, a leader in providing online transparency tools and data that help consumers find top doctors and make informed decisions about their medical care, is pleased to announce that Dr. Carlos Ayala has been honored with the prestigious 2014 Vitals Patients. Choice Award. The Award, now in its seventh year, is a widely recognized distinction bestowed on doctors by the people they care for — their patients.

Each year, Vitals receives millions of patient-reported ratings on various components of their doctor’s care, including accuracy of their diagnosis, the amount of time they spent with the doctor, and the doctor’s bedside manner and follow-up care.

Vitals Patients. Choice Award winners must receive an overall rating of at least 3.5 or higher (out of 4.0). Winning doctors must also have a medical license in good standing with no sanctions. Of the nation’s 1 million active physicians and dentists, just 5 percent qualified for this honor in 2014.

Dr. Carlos Ayala commented on the recognition:

About Carlos Ayala: a short profile by and about the honoree:

Dr. Carlos Ayala served over 26 yrs active duty in the U.S. military and recently retired from the United States Air Force as a Lieutenant Colonel. A veteran of the war in Afghanistan and supporter of our nation’s veterans. Dr Ayala specializes in Rhinoplasty, Revision Rhinoplasty, Balloon Sinuplasty, Blepharoplasty, Otoplasty, Facial Plastic Surgery, and Allergy. Dr Ayala is Double Board Certified in Otolaryngology and Facial Plastic Surgery, and a Fellow of the American College of Surgeons His office is located at 800 E Dove Ave Suite F & G Mcallen, Tx 78504

“Doctors recognized with a Vitals Patients. Choice award are committed to the patient experience,” said Mitch Rothschild, CEO of Vitals. “We commend these doctors for bringing both compassion and expertise to the practice of medicine.”

Following the publication of Dr. Carlos Ayala‘s selection for the Vitals Patient’s Choice Award, American Registry seconded the honor and added Dr. Carlos Ayala to The Registyr™ of Business Excellence. An exclusive recognition plaque has been designed to commemorate the honor. The doctor’s custom wall plaque is shown here.

To learn more about the doctor and see the award, please visit Dr. Carlos Ayala‘s profile on Vitals.com.

About Vitals
Vitals is reinventing the way people shop and save on their medical care. We support effective decision-making through cost, quality and access data, as well as reward and incentive programs. Vitals leads the market with the first transparency and engagement platform that achieves measurable savings for consumers through a retail-like approach to purchasing health care services. Through health plans, hospitals and our leading consumer websites, Vitals helps more than 150 million people each year access better, more affordable care.

MIS® Implants Technologies and NBMolecules® conclude a License and Supply Agreement for use of the novel technology SurfLink® for treatment of MIS dental implants

The unique bio-mimicking traits and the cost-effectiveness of the SurfLink® surface treatment are clear differentiators from all competing solutions.

BAR LEV (IL) and GLAND (CH) July 27, 2015 – MIS Implants Technologies Ltd and Nano Bridging Molecules SA announced today they have concluded a License and Supply Agreement for the advanced surface treatment technology SurfLink®, manufactured by NBMolecules®. “We are very proud of this commercial agreement with MIS, which will allow patients to benefit from the unique combination of a leading quality dental implant and a unique bio-mimicking surface” says Bjorn-Owe Aronsson, Executive Director and Founder of NBMolecules®.

The agreement between the world leading dental implant company MIS and the start-up NBMolecules® will give MIS the exclusive rights to manufacture and sell their titanium based dental implants with the clinically proven SurfLink® surface.

SurfLink® consists of a permanently bound layer of phosphorous-rich molecules, which is applied to the implant surface to enhance osseointegration. The SurfLink® surface is seen as bone-like by the body.

Clinical studies have shown SurfLink® maintains marginal bone levels over time, giving reproducible clinical results and predictable osseointegration.

MIS, a frontrunner of innovation, is committed to achieve the highest possible implant surface quality to give patients the best that science can offer. “This agreement with NBMolecules® is an important stage in our efforts to offer our customers real innovation, based on cutting edge and proven technology. It will allow us to give our dental surgeons access to truly world leading dental implants” says Idan Kleifeld, CEO of MIS.

About MIS Implants Technologies Ltd.

Established in 1995, MIS Implants Technologies Ltd. is a global leader in the development and production of advanced products and innovative solutions aimed to simplify implants dentistry. Through state-of-the-art production facilities, MIS offers a comprehensive range of cutting-edge dental implants, superstructures, tools and kits, as well as extensive solutions for oral restoration and health.

MIS is deeply committed to its core values of quality, service, agility and innovation, integrity and caring, reflected in every step of its work process and supported by over 400 dedicated MIS employees. MIS products are distributed in over 60 countries worldwide through a well-established global distribution network.

About Nano Bridging Molecules SA

NBMolecules®, a privately held Swiss Medical Device company founded in 2002, is dedicated to developing and licensing out advanced surface treatments for bone anchored implants. NBMolecules® is ISO 13485 certified and SurfLink® is its first surface technology, which is manufactured in-house. SurfLink® has been developed over a period of 15 years and has been proven to achieve true bone integration. NBMolecules® is committed to excellence in both science and product quality. A small core team manages the NBM’s day to day business. Over 65 contracts with research institutions and other external service providers have been established, and the company continues to grow.

For more information, please visit www.NBMolecules.com and www.MIS-implants.com or

Contact:

Bjorn-Owe Aronsson
Nano Bridging Molecules SA
info@NBMolecules.com

MIS® Implants Technologies and NBMolecules® conclude a License and Supply Agreement for use of the novel technology SurfLink® for treatment of MIS dental implants

The unique bio-mimicking traits and the cost-effectiveness of the SurfLink® surface treatment are clear differentiators from all competing solutions.

BAR LEV (IL) and GLAND (CH) July 27, 2015 – MIS Implants Technologies Ltd and Nano Bridging Molecules SA announced today they have concluded a License and Supply Agreement for the advanced surface treatment technology SurfLink®, manufactured by NBMolecules®. “We are very proud of this commercial agreement with MIS, which will allow patients to benefit from the unique combination of a leading quality dental implant and a unique bio-mimicking surface” says Bjorn-Owe Aronsson, Executive Director and Founder of NBMolecules®.

The agreement between the world leading dental implant company MIS and the start-up NBMolecules® will give MIS the exclusive rights to manufacture and sell their titanium based dental implants with the clinically proven SurfLink® surface.

SurfLink® consists of a permanently bound layer of phosphorous-rich molecules, which is applied to the implant surface to enhance osseointegration. The SurfLink® surface is seen as bone-like by the body.

Clinical studies have shown SurfLink® maintains marginal bone levels over time, giving reproducible clinical results and predictable osseointegration.

MIS, a frontrunner of innovation, is committed to achieve the highest possible implant surface quality to give patients the best that science can offer. “This agreement with NBMolecules® is an important stage in our efforts to offer our customers real innovation, based on cutting edge and proven technology. It will allow us to give our dental surgeons access to truly world leading dental implants” says Idan Kleifeld, CEO of MIS.

About MIS Implants Technologies Ltd.

Established in 1995, MIS Implants Technologies Ltd. is a global leader in the development and production of advanced products and innovative solutions aimed to simplify implants dentistry. Through state-of-the-art production facilities, MIS offers a comprehensive range of cutting-edge dental implants, superstructures, tools and kits, as well as extensive solutions for oral restoration and health.

MIS is deeply committed to its core values of quality, service, agility and innovation, integrity and caring, reflected in every step of its work process and supported by over 400 dedicated MIS employees. MIS products are distributed in over 60 countries worldwide through a well-established global distribution network.

About Nano Bridging Molecules SA

NBMolecules®, a privately held Swiss Medical Device company founded in 2002, is dedicated to developing and licensing out advanced surface treatments for bone anchored implants. NBMolecules® is ISO 13485 certified and SurfLink® is its first surface technology, which is manufactured in-house. SurfLink® has been developed over a period of 15 years and has been proven to achieve true bone integration. NBMolecules® is committed to excellence in both science and product quality. A small core team manages the NBM’s day to day business. Over 65 contracts with research institutions and other external service providers have been established, and the company continues to grow.

For more information, please visit www.NBMolecules.com and www.MIS-implants.com or

Contact:

Bjorn-Owe Aronsson
Nano Bridging Molecules SA
info@NBMolecules.com

Dr. Carlos Ayala Wins Prestigious Vitals Patients’ Choice Award

Seventh Annual Vitals Patients. Choice Award Recognizes Dr. Carlos Ayala for Outstanding Care Based on Patient Feedback

Mcallen, TX — July 24, 2015 — Vitals, a leader in providing online transparency tools and data that help consumers find top doctors and make informed decisions about their medical care, is pleased to announce that Dr. Carlos Ayala has been honored with the prestigious 2014 Vitals Patients. Choice Award. The Award, now in its seventh year, is a widely recognized distinction bestowed on doctors by the people they care for — their patients.

Each year, Vitals receives millions of patient-reported ratings on various components of their doctor’s care, including accuracy of their diagnosis, the amount of time they spent with the doctor, and the doctor’s bedside manner and follow-up care.

Vitals Patients. Choice Award winners must receive an overall rating of at least 3.5 or higher (out of 4.0). Winning doctors must also have a medical license in good standing with no sanctions. Of the nation’s 1 million active physicians and dentists, just 5 percent qualified for this honor in 2014.

Dr. Carlos Ayala commented on the recognition:

About Carlos Ayala: a short profile by and about the honoree:

Dr. Carlos Ayala served over 26 yrs active duty in the U.S. military and recently retired from the United States Air Force as a Lieutenant Colonel. A veteran of the war in Afghanistan and supporter of our nation’s veterans. Dr Ayala specializes in Rhinoplasty, Revision Rhinoplasty, Balloon Sinuplasty, Blepharoplasty, Otoplasty, Facial Plastic Surgery, and Allergy. Dr Ayala is Double Board Certified in Otolaryngology and Facial Plastic Surgery, and a Fellow of the American College of Surgeons His office is located at 800 E Dove Ave Suite F & G Mcallen, Tx 78504

“Doctors recognized with a Vitals Patients. Choice award are committed to the patient experience,” said Mitch Rothschild, CEO of Vitals. “We commend these doctors for bringing both compassion and expertise to the practice of medicine.”

Following the publication of Dr. Carlos Ayala‘s selection for the Vitals Patient’s Choice Award, American Registry seconded the honor and added Dr. Carlos Ayala to The Registyr™ of Business Excellence. An exclusive recognition plaque has been designed to commemorate the honor. The doctor’s custom wall plaque is shown here.

To learn more about the doctor and see the award, please visit Dr. Carlos Ayala‘s profile on Vitals.com.

About Vitals
Vitals is reinventing the way people shop and save on their medical care. We support effective decision-making through cost, quality and access data, as well as reward and incentive programs. Vitals leads the market with the first transparency and engagement platform that achieves measurable savings for consumers through a retail-like approach to purchasing health care services. Through health plans, hospitals and our leading consumer websites, Vitals helps more than 150 million people each year access better, more affordable care.

Derek Muhs of HCMC and WA Health Care Nominated for Excellence in Branding & Marketing

Derek Muhs

Health Care Management China (HCMC) today announced that Co-Founder and Vice Chairman Derek Muhs has been nominated for Excellence in Branding and Marketing by the Awards Jury of the 6th Annual CMO ASIA AWARDS, to be held in Singapore on August 11, 2015.

HCMC and WA Health Care are nominated for “Best brand in private health care center in China”. The Asia Awards for Excellence in Branding & Marketing is a premium forum bringing elite marketers, brand custodians and creative heads together to collaborate and recognize excellence in the industry. Other nominees and speakers on the agenda include General Electric Healthcare, Twitter, Grant Thornton International and Standard Chartered Bank.

HCMC and its group of health care initiatives, including WA Health Care, have been recognized for their promotion of health care education and illness prevention across China. See one of their former health campaigns about the state of health in China here

You May Need a Social Security Disability Lawyer

52213Social Security guidelines are becoming more stringent all the time. Many people have little understanding of them. When the time comes to apply for disability, they don’t know what to do, and they may unintentionally delay or destroy their chance of a successful verdict without adequate legal assistance.

A competent law firm that specializes in disability law can be a tremendous asset for someone who has become disabled. Attorneys practicing in this area understand how the law works and applies to various situations. They can advise a client of his or her potential for winning a successful disability award. Disability attorneys can prep clients for legal proceedings like interrogatories and courtroom testimony, if relevant.

If you are looking for a disability law firm, find one that specializes in disability law. Look for evidence of previous court victories, as well as a solid reputation within the legal and local communities. Check with the local bar association to see if there are any unresolved complaints or disputes. Also consult the Better Business Bureau for a record of similar issues. If these records are clear, that is a good first step.

The next step may be to consult the attorney you have in mind for an interview. Have a brief timeline of events ready for discussion, along with a list of questions about your case. Attorneys who support clients with disability claims are often compassionate and serve as aggressive advocates for their legal rights.

Some people are born disabled, while others become injured or ill in such a way as to constitute a legal disability. Attorneys who are trained in this area of law can explain legal guidelines, definitions, and procedures to help someone understand how the law views their circumstances. Some situations may not be eligible for legal compensation, while others might be. Most of us don’t know the difference. That is why a disability specialist in the law can be a helpful resource to someone who is trying to determine whether he or she deserves a disability designation and support.

Everyone in our society deserves a fair chance to live a meaningful life. A disability specialist can make the difference between success and failure if the claim goes to court. It is in a prospective client’s best interests to consult a qualified law firm like www.parmelelawfirm.com for information about the laws that govern disability and Social Security issues. A caring, knowledgeable law firm like this one has answers to important questions you may have.

Benefits of Using Knee Sleeves

workoutIf you are experiencing knee pain while working out then using rogue knee sleeves might help you in your quest to work out without experiencing any pain. Working out is an important part of many people’s day and having pain get in the way of a good workout is not a good thing. One doesn’t want to stop working out just because they are experiencing a bit of pain, but no one wants to work out while in pain. Working out is not only a fun activity to engage in, but it is also important to a persons health to continue to work out. But doing so while in pain can be nearly impossible, particularly if the pain comes from the knee. The answer for not experiencing knee pain while working out is quite simple and won’t cramp your style in the least.

Rogue knee sleeves can help a person to not experience pain while working out because of the high quality materials that they are made out of. Knee sleeves allow the person to continue working out while ensuring that the knee stays in its proper position while a person is performing the work outs. The knee sleeve helps prevent the knee from moving around too much while the person is working out. This may seem like it is counter-productive, as mobility is important for many different work outs, but in reality when it comes to the knee having the mobility inhibited can be very essential. The bones in the knee moving around in a way that they are not supposed to can be a very painful experience and can hinder a person’s workout routine. Knee sleeves can prevent the bones from moving around by tightly encasing the knee in quality stretching material.

It may also seem like a knee sleeve would be an uncomfortable addition to your workout attire whereas this could not be farther from the truth. Having a knee sleeve can ensure a persons comfort during the workout not only because of the high quality material it is made out of, but the fact that it also keeps the bones of the knee in place. A knee sleeve can be worn on one or both knees, depending upon which knee the person is feeling pain. It does not matter if a person wears a knee sleeve on only one knee or chooses to wear the knee sleeve on both knees. The deciding factor is simply where a person feels pain at the time. If the person feels pain in one knee then they should wear the knee sleeve on one knee. If there is pain in both knees, then it should be worn on both knees.